APO-1

N/A

Report date: 2022/12/17 23:45:46

Base Information

Drug NameAPO-1
Drug Alias NameAPOSECAPO-1APO-1001APO-2
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionEpithelial cells stimulantsApoptosis inhibitorsAngiogenesis inducers +[4] 
TargetsNot applicable
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaPolandAustria +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAposcience Ag
China Registration ClassN/A

Develop Information

Active CompaniesAposcience Ag
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A